On the Evidence No clinical trial has tested GHK-Cu in rosacea patients specifically, and any claim citing one should be treated as unverified until a real citation is produced
It is safe for most skin types, including sensitive and acne-prone skin
Targeting Wnt/-Catenin Pathway for Developing Therapies for Hair Loss
Foods such as brazil nuts, fish, sunflower seeds, and bananas are all selenium-containing
Cost Over Time and Ongoing Commitment Injectable GHK-Cu requires a significant financial commitment, as prices typically range from $239 to over $300 per vial, depending on dosage
Retatrutide is in Phase 3 clinical trials through Eli Lilly, and cagrilintide is in Phase 3 trials through Novo Nordisk (both as monotherapy and as part of CagriSema)